Klox Technologies Inc a Canada-based regenerative medicine company focused on the development and commercialisation of its proprietary fluorescent light energy biomodulation System (FB System) in dermatology, wound care, and animal health, announced yesterday that it has named Domenic Serafino and Dr Richard Markoff as its new directors.
Serafino is a medical device veteran, with more than 25 years of experience. Presently, he serves as chairman and CEO of Venus Concept with direct operations in 27 of these markets and over 500 employees. He brings extensive experience in sales, marketing and global operations.
Dr Markoff has more than 25 years' experience as a supply chain executive. He is co-founder and partner at Innovobot and earlier managed Global Supply Chain Standards at L'Oreal cosmetics. He holds a PhD in Supply Chain Management and is a lecturer and researcher at Ecole polytechnique federale de Lausanne and the International Institute for Management Development in Switzerland.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval